March 1, 2018 / 12:21 PM / 9 months ago

BRIEF-Paratek Pharmaceuticals Reports Q4 Loss Per Share $0.78

March 1 (Reuters) - Paratek Pharmaceuticals Inc:

* PARATEK PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND REMAINS ON TRACK FOR COMMERCIAL LAUNCH BY FIRST QUARTER 2019

* Q4 LOSS PER SHARE $0.78

* Q4 EARNINGS PER SHARE VIEW $-0.75 -- THOMSON REUTERS I/B/E/S

* AS OF DECEMBER 31, 2017, PARATEK HAD CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES OF $151.7 MILLION‍​ Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below